FY2024 EPS Estimates for Ayr Wellness Cut by Atb Cap Markets

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Investment analysts at Atb Cap Markets decreased their FY2024 earnings per share (EPS) estimates for shares of Ayr Wellness in a report issued on Sunday, December 8th. Atb Cap Markets analyst F. Gomes now expects that the company will earn ($1.38) per share for the year, down from their prior forecast of ($1.34). Atb Cap Markets currently has a “Strong Sell” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.32) EPS and FY2025 earnings at ($1.13) EPS.

A number of other brokerages have also recently issued reports on AYRWF. Roth Mkm cut their price objective on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a report on Thursday, November 14th. Roth Capital upgraded Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th.

Ayr Wellness Stock Down 9.1 %

Shares of AYRWF stock opened at $0.40 on Wednesday. The stock has a market cap of $45.66 million, a P/E ratio of -0.18 and a beta of 1.54. Ayr Wellness has a one year low of $0.40 and a one year high of $4.09. The stock has a fifty day moving average price of $1.33 and a 200 day moving average price of $1.74. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.59 and a quick ratio of 0.58.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.